Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+53.6%
5Y CAGR+77.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+53.6%/yr
Annual compound
5Y CAGR
+77.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
17.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $226.65M | +192.9% |
| 2024 | $77.39M | -54.5% |
| 2023 | $170.20M | +172.2% |
| 2022 | $62.53M | +24.6% |
| 2021 | $50.19M | +289.8% |
| 2020 | $12.88M | +320.1% |
| 2019 | $3.06M | - |